substance p has been researched along with Bladder Diseases in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Laudon, V; Li, Y; Liu, Y; Shi, B; Wang, D; Wang, P; Zhang, J | 1 |
Burmester, M; Jonas, U; Lietz, B; Machtens, SA; Stief, CG; Uckert, S | 1 |
Chen, WC; Chien, CT; Hayakawa, S; Lai, MK; Shimizu, K | 1 |
Akici, A; Ercan, F; Erin, N; Ersoy, Y; Hürdag, C | 1 |
Chen, CJ; Chen, WC; Chien, CT; Hayakawa, S; Li, PC; Lu, WA; Shih, CC; Shimizu, K | 1 |
Bales, GT; Cook, SP; Lotan, TL; Lucioni, A; McGehee, DS; Rapp, DE | 1 |
Ahlman, H; Dahlstrand, C; Dahlström, A; Jonsson, O; Lundstam, S; Norlén, L; Pettersson, S | 1 |
7 other study(ies) available for substance p and Bladder Diseases
Article | Year |
---|---|
Nerve growth factor and substance P: expression in a rat model of diabetic bladder.
Topics: Animals; Diabetes Mellitus, Experimental; Enzyme-Linked Immunosorbent Assay; Gene Expression; Immunohistochemistry; Male; Nerve Growth Factor; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA; Substance P; Urinary Bladder Diseases | 2011 |
Possible role of bioactive peptides in the regulation of human detrusor smooth muscle - functional effects in vitro and immunohistochemical presence.
Topics: Atrial Natriuretic Factor; Calcitonin Gene-Related Peptide; Endothelin-1; Female; Humans; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Peptides; Substance P; Urinary Bladder; Urinary Bladder Diseases; Vasoactive Intestinal Peptide | 2002 |
Catechins prevents substance P-induced hyperactive bladder in rats via the downregulation of ICAM and ROS.
Topics: Animals; Antioxidants; Blood Pressure; Blotting, Western; Catechin; Cell Adhesion Molecules; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; Female; Gene Expression Regulation; Immunohistochemistry; Leukocytes; Rats; Rats, Wistar; Reactive Oxygen Species; Substance P; Urinary Bladder; Urinary Bladder Diseases; Vasodilation | 2004 |
Inhibition of substance P activity prevents stress-induced bladder damage.
Topics: Animals; Cell Degranulation; Dose-Response Relationship, Drug; Injections, Intraventricular; Mast Cells; Neurokinin-1 Receptor Antagonists; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Sodium Chloride; Stress, Physiological; Substance P; Urinary Bladder Diseases; Urothelium | 2006 |
Combination of Wu Lin San and Shan Zha ameliorates substance P-induced hyperactive bladder via the inhibition of neutrophil NADPH oxidase activity.
Topics: Animals; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Hyperkinesis; Inhibition, Psychological; NADPH Oxidases; Neutrophils; Rats; Rats, Wistar; Reactive Oxygen Species; Substance P; Urinary Bladder; Urinary Bladder Diseases; Vasodilation | 2006 |
Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation.
Topics: Animals; Botulinum Toxins, Type A; Calcitonin Gene-Related Peptide; Male; Neuromuscular Agents; Rats; Rats, Sprague-Dawley; Substance P; Urinary Bladder; Urinary Bladder Diseases; Urodynamics | 2008 |
Effect of substance P on detrusor muscle in rats with diabetic cystopathy.
Topics: Animals; Diabetes Mellitus, Experimental; Muscle Contraction; Muscles; Pressure; Rats; Rats, Sprague-Dawley; Substance P; Urinary Bladder; Urinary Bladder Diseases; Urination; Urodynamics | 1992 |